- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Mar 6, 2025
Highlights
- Market Cap
- $1.10B
- Enterprise Value
- $808.41M
- EPS (TTM)
- -$2.79
- Total Revenue (TTM)
- $83.72M
- Gross Profit (TTM)
- $40.81M
- EBITDA (TTM)
- -$132.51M
- Year Range
- $13.25 - $30.00
- Target Price
- $28.00
- ROA (TTM)
- -38.18%
- ROE (TTM)
- -50.29%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
KMTS Performance Chart
Kestra Medical Technologies, Ltd. (KMTS) is down 21.8% since the beginning of the year. At $21 per share, KMTS is trading 30.9% below its 52-week high of $30.
Loading charts...
Returns By Period
Kestra Medical Technologies, Ltd. (KMTS) has returned -21.83% so far this year and 37.92% over the past 12 months.
Kestra Medical Technologies, Ltd.
- 1D
- 4.01%
- 1M
- -4.21%
- YTD
- -21.83%
- 6M
- -25.99%
- 1Y
- 37.92%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
KMTS Monthly Returns History
Based on dividend-adjusted daily data since Mar 6, 2025, KMTS's average daily return is +0.05%, while the average monthly return is +0.38%. At this rate, an investment would double in approximately 15.2 years.
Historically, 31% of months were positive and 69% were negative. The best month was Sep 2025 with a return of +47.2%, while the worst month was Jun 2025 at -26.4%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 5 months.
On a daily basis, KMTS closed higher 52% of trading days. The best single day was Sep 12, 2025 with a return of +18.6%, while the worst single day was Mar 12, 2026 at -14.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.98% | -5.63% | -14.39% | 3.96% | 2.61% | -2.49% | -21.83% | ||||||
| 2025 | 8.58% | -3.45% | -6.40% | -26.38% | -0.48% | -2.18% | 47.21% | 15.24% | -1.46% | -1.70% | 15.56% |
Benchmark Metrics
Kestra Medical Technologies, Ltd. has an annualized alpha of -13.20%, beta of 1.34, and R2 of 0.13 versus S&P 500 Index. Calculated based on daily prices since March 06, 2025.
- This stock participated in 155.60% of S&P 500 Index downside but only 24.49% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.13 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -13.20%
- Beta
- 1.34
- R²
- 0.13
- Upside Capture
- 24.49%
- Downside Capture
- 155.60%
Return for Risk
Risk / Return Rank
KMTS ranks 62 for risk / return — better than 62% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Kestra Medical Technologies, Ltd. (KMTS) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KMTS | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.45 | ||
| Sortino ratioReturn per unit of downside risk | -1.53 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.37 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 1.05 | 2.78 | -1.73 |
| Martin ratioReturn relative to average drawdown | 2.27 | 12.44 | -10.17 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Kestra Medical Technologies, Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Kestra Medical Technologies, Ltd. was 43.74%, occurring on Aug 6, 2025. Recovery took 33 trading sessions.
The current Kestra Medical Technologies, Ltd. drawdown is 25.99%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 bear market2025 | -43.74%Aug 2025 | 4mo 5d | 1mo 18d | 5mo 23dApr 2025 - Sep 2025 |
2026 bear market2026 | -36.20%Apr 2026 | 3mo 18d | — | 6mo 2dDec 2025 - now |
2025 correction2025 | -17.72%Dec 2025 | 1mo 2d | 20d | 1mo 22dOct 2025 - Dec 2025 |
2025 correction2025 | -14.53%Oct 2025 | 16d | 10d | 26dSep 2025 - Oct 2025 |
2025 selloff2025 | -11.07%Mar 2025 | 7d | 4d | 11dMar 2025 - Mar 2025 |
Drawdown Indicators
| KMTS | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.74% | -56.78% | +13.04% |
Max Drawdown (1Y)Largest decline over 1 year | -36.20% | -9.10% | -27.10% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -25.99% | -1.80% | -24.19% |
Average DrawdownAverage peak-to-trough decline | -17.86% | -10.71% | -7.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.73% | 2.03% | +14.70% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Kestra Medical Technologies, Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Kestra Medical Technologies, Ltd. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for KMTS relative to other companies in the Medical Instruments & Supplies industry. Currently, KMTS has a P/S ratio of 12.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for KMTS in comparison with other companies in the Medical Instruments & Supplies industry. Currently, KMTS has a P/B value of 3.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with KMTS
Add Kestra Medical Technologies, Ltd. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with KMTS